Surgical vs medical treatments for type 2 diabetes mellitus: A randomized clinical trial

JAMA Surgery

Volumn 149, Issue 7, 2014, Pages 707-715

  Courcoulas, Anita P ^a   Goodpaster, Bret H ^b,c   Eagleton, Jessie K ^a   Belle, Steven H ^d   Kalarchian, Melissa A ^b,e   Lang, Wei ^f   Toledo, Frederico G S ^b   Jakicic, John M ^g  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c FLORIDA HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e DUQUESNE UNIVERSITY   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C;

ABDOMINAL PAIN; ADULT; APPLICATION SITE REACTION; ARTICLE; BARIATRIC SURGERY; BODY MASS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEHYDRATION; FEASIBILITY STUDY; FEMALE; GASTRIC BANDING; GLYCEMIC CONTROL; HOSPITAL READMISSION; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; JEJUNUM ULCER; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL PROCEDURES; MIDDLE AGED; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROUX Y ANASTOMOSIS; SMOKING; STOMACH BYPASS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WEIGHT REDUCTION; YOUNG ADULT;

ADULT; BARIATRIC SURGERY; BODY MASS INDEX; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEASIBILITY STUDIES; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; REMISSION INDUCTION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84904406952     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.467     Document Type: Article

References (30)

1. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21):2240-2249.
2. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577-1585.
3. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567-1576.
4. Wolfe BM, Purnell JQ, Belle SH. Treating diabetes with surgery. JAMA. 2013;309(21):2274-2275.
5. Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308(11):1122-1131.
6. Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695-704.
7. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323. (Pubitemid 351159368)
8. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467-485. (Pubitemid 38176385)
9. Unger RH. Reinventing type 2 diabetes: pathogenesis, treatment, and prevention. JAMA. 2008;299(10):1185-1187. (Pubitemid 351398434)
10. Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309(21):2250-2261.
11. National Institutes of Health. Recovery Act limited competition: NIH Challenge Grants in Health and Science Research (RC1). http://grants.nih.gov/ grants/guide/rfa-files/rfa-od-09-003.html. Accessed June 17, 2013.
12. Lautz D, Halperin F, Goebel-Fabbri A, Goldfine AB. The great debate: medicine or surgery: what is best for the patient with type 2 diabetes? Diabetes Care. 2011;34(3):763-770.
13. ClinicalTrials.gov. Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes (SLIMM-T2D). NLM Identifier: NCT01073020. http://clinicaltrials.gov/show/NCT01073020. Accessed June 17, 2013.
14. ClinicalTrials.gov. Surgery or Lifestyle Intervention for Type 2 DIabetes (SOLID). NLM Identifier: NCT01040468. In: http://clinicaltrials.gov/show/ NCT01040468. Accessed July 3, 2013.
15. ClinicalTrials.gov. Calorie Reduction or Surgery: Seeking Remission for Obesity and Diabetes (CROSSROADS). NLM Identifier: NCT01295229. http://clinicaltrials.gov/show/NCT01295229. Accessed June 17, 2013.
16. ClinicalTrials.gov. Beth Israel Deaconess Medical Center: Apnea, Bariatric Surgery vs Continuous Positive Airway Pressure (CPAP) Trial (ABC). NLM Identifier: NCT01187771. http://clinicaltrials.gov/show/NCT01187771. July 3, 2013.
17. ClinicalTrials.gov. Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes (Stampede II). NLM Identifier: NCT01278823. http://clinicaltrials.gov/ show/NCT01278823. Accessed July 3, 2013.
18. ClinicalTrials.gov. Improving Diabetes Through Lifestyle and Surgery (IDeaLS). NLM Identifier: NCT01667783. http://clinicaltrials.gov/show/ NCT01667783. Accessed June 17, 2013.
19. Wing RR; Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566-1575.
20. Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165-2171.
21. Ryan DH, Espeland MA, Foster GD, et al Look AHEAD Research Group. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24(5):610-628. (Pubitemid 38366013)
22. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133-2135.
23. Borradaile KE, Halpern SD, Wyatt HR, et al. Relationship between treatment preference and weight loss in the context of a randomized controlled trial. Obesity (Silver Spring). 2012;20(6):1218-1222.
24. Consensus Development Conference Panel. NIH Conference: gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115(12):956-961.
25. Gourash WF, Ebel F, Lancaster K, et al. Longitudinal Assessment of Bariatric Surgery (LABS): retention strategy and results at 24 months. Surg Obes Relat Dis. 2013;9(4):514-519.
26. Pi-Sunyer X, Blackburn G, Brancati FL, et al Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care. 2007;30(6):1374-1383. (Pubitemid 46871141)
27. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? an operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339-352.
28. O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625-633. (Pubitemid 46780646)
29. O'Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87-94.
30. Gregg EW, Chen H, Wagenknecht LE, et al Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308(23):2489-2496.